Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Acta Neurol Scand ; 138(4): 308-314, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29740825

ABSTRACT

BACKGROUND: The existing reports regarding the potential role of infections as well as antibiotic use in multiple sclerosis (MS) etiology are inconclusive. OBJECTIVES: We aimed to investigate the association of viral infections as well as antibiotic use and the risk of developing MS. MATERIALS & METHODS: This was a population-based incident case-control study of 547 incident cases and 1057 general population controls obtained from 22 municipality areas of Tehran (7/8/2013-17/2/2015). Multiple logistic regression models were used to determine the adjusted associations. RESULTS: Overall antibiotic use for ≥14 days during 3 years before the index date, significantly decreased the odds of MS OR 0.69 (95%CI: 0.53-0.91, P = .008). The results were consistent for different types of antibiotics, including penicillin OR 0.50 (95%CI: 0.34-0.75, P = .001) and cephalosporins OR 0.25 (95%CI: 0.12-0.50, P < .001). History of IM was associated with a more than 5fold increased risk of MS OR = 5.7 (95%CI, 1.28-25.37). There was no statistically significant association between any other single or cumulative number of viral infections with subsequent risk of MS (P > .05). CONCLUSIONS: Considering the possibility of reverse causation, the results of this large case-control study suggest that use of antibiotics may be associated with a decreased risk of MS. However, viral disease other than infectious mononucleosis was not associated with MS risk.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Multiple Sclerosis/drug therapy , Multiple Sclerosis/epidemiology , Population Surveillance , Virus Diseases/drug therapy , Virus Diseases/epidemiology , Adult , Case-Control Studies , Female , Humans , Incidence , Infectious Mononucleosis/diagnosis , Infectious Mononucleosis/drug therapy , Infectious Mononucleosis/epidemiology , Iran/epidemiology , Male , Middle Aged , Multiple Sclerosis/diagnosis , Population Surveillance/methods , Registries , Risk Factors , Virus Diseases/diagnosis , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL